This document discusses the management of patients with duct dependent circulation. It describes various cardiac conditions that rely on the ductus arteriosus remaining patent, such as pulmonary atresia. It outlines signs that should prompt consideration of duct dependency, like cyanosis or shock. The use of prostaglandin E1 infusion to maintain ductal patency is described in detail, including monitoring for side effects and adjusting the infusion rate based on clinical response. Other options to ensure mixing of blood or keep shunts open such as atrial septostomy or valvuloplasty are mentioned. The importance of recognizing duct dependency and starting prostaglandin treatment promptly when indicated is emphasized.